Patents by Inventor Steven N. Mink

Steven N. Mink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ethylgallate and related compounds as a treatment for sepsis and septic shock
    Patent number: 8772339
    Abstract: The use of ethyl gallate methyl gallate or 3,4-dihydroxybenzoate for treatment of septic shock Said compounds may also prophylactically treat septic shock via administration to a subject before the development of a fall in blood pressure.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: July 8, 2014
    Inventors: Steven N. Mink, Hans Jacobs
  • Ethylgallate and Related Compounds as a Treatment for Sepsis and Septic Shock
    Publication number: 20120277312
    Abstract: The use of ethyl gallate methyl gallate or 3,4-dihydroxybenzoate for treatment of septic shock Said compounds may also prophylactically treat septic shock via administration to a subject before the development of a fall in blood pressure.
    Type: Application
    Filed: February 24, 2010
    Publication date: November 1, 2012
    Inventors: Steven N. Mink, Hans Jacobs
  • Methods of treating inflammation
    Patent number: 7402575
    Abstract: Methods and compositions for treating myocardial dysfunction or inflammation are described. The methods of the invention involve administering an agent that can inhibit lysozyme to an animal in need thereof. Preferred lysozyme inhibitors include TAC and chitobiose.
    Type: Grant
    Filed: January 23, 2004
    Date of Patent: July 22, 2008
    Inventors: Steven N. Mink, Hans Jacobs, Deepak Bose, Krika Duke, R. Bruce Light
  • Methods of treating inflammation
    Publication number: 20040214792
    Abstract: Methods and compositions for treating myocardial dysfunction or inflammation are described. The methods of the invention involve administering an agent that can inhibit lysozyme to an animal in need thereof. Preferred lysozyme inhibitors include TAC and chitobiose.
    Type: Application
    Filed: January 23, 2004
    Publication date: October 28, 2004
    Inventors: Steven N. Mink, Hans Jacobs, Deepak Bose, Krika Duke, R. Bruce Light